Aura Biosciences secures $8 million in additional funding and augments Board of Directors and Clinical Advisory Board

by Ysios Capital

The round of financing consisted of expanded funding commitments from its existing investors: Advent Partners, Chiesi Ventures, Ysios Capital, Alexandria Venture Investments and several individual inv...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

SICC Innvierte, a vehicle managed by CDT...

by CDTI Innovación

With a target size of €250 million, the fund aims to complete betwee...

Photos Stream